Contrast Media Market worth $6.0 billion by 2024
According to research report the global contrast media market
is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0
billion in 2019, growing at a CAGR of 3.8% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
Growth
in the contrast agent market can primarily be attributed to factors
such as the increasing prevalence of cancer & CVD, regulatory
approval of a growing number of contrast agents, and the rising volume
of CT & MRI examinations. However, the side effects and allergic
reactions associated with contrast agents are expected to limit market
growth to a certain extent.
North America to dominate the market in 2019
North
America, Europe, Asia Pacific, and the Rest of the World (RoW) are the
regions considered for geographic analysis of the global contrast agent
market study. North America is expected to account for the largest share
of the global contrast media industry. The large share of North America
is attributed to the increasing number of diagnostic imaging units and
examinations, growing aging population & rising prevalence of
chronic conditions in the US, significant focus & government
investments in the field of medical imaging, and increasing research
activities in Canada.
Get 10% FREE Customization on This Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=911
By type, the iodinated contrast media segment is expected to account for the largest share of the contrast media market in 2019
Based
on type, the contrast media market is segmented into iodinated contrast
media, gadolinium-based contrast media, barium-based contrast media,
and microbubble contrast media. In 2019, the iodinated contrast media
segment is estimated to account for the largest share of the contrast
media industry. The large share of this segment can be attributed due to
its high usage in CT examinations coupled with the fact that it can be
used in almost all body parts.
By modality, the X-ray/CT segment is expected to account for the largest share of the market in 2019
Based
on modality, the market is segmented into X-ray/CT, MRI, and ultrasound
procedures. In 2019, X-ray/CT procedures segment is expected to command
the largest share of the global contrast media market. The large share
of this segment can be attributed to the increasing number of CT
examinations across the globe, coupled with advancements in CT imaging
technologies.
The prominent players in the global contrast media
market include GE Healthcare (US), Bracco Imaging (Italy), Bayer
(Germany), and Guerbet (France) are the major players operating in the
market. Other prominent players in the market are Lantheus (US), Daiichi
Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Sanochemia
(Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health
(India).
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
Comments
Post a Comment